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Abstract: Hydrogels are widely used in various biomedical
applications, as they cannot only serve as materials for
biofabrication but also as depots for the administration of
drugs. However, the possibilities of formulation of water-
insoluble drugs in hydrogels are rather limited. Herein, we
assembled recombinant spider silk gels using a new processing
route with aqueous–organic co-solvents, and the properties of
these gels could be controlled by the choice of the co-solvent.
The presence of the organic co-solvent further enabled the
incorporation of hydrophobic drugs as exemplarily shown for
6-mercaptopurine. The developed gels showed shear-thinning
behaviour and could be easily injected to serve, for example, as
drug depots, and they could even be 3D printed to serve as
scaffolds for biofabrication. With this new processing route, the
formulation of water-insoluble drugs in spider silk-based
depots is possible, circumventing common pharmaceutical
solubility issues.
Hydrogels are used for biomedical applications such as
tissue engineering, drug delivery, and recently also biofabri-
cation.[1] Besides polysaccharides, such as alginate[2] or
chitosan,[3] proteins such as Bombyx mori silkworm silk[4] or
gelatine[5] have been processed into hydrogels using various
methods. Also, hydrogel formation of the recombinant spider
silk protein eADF4(C16), which is engineered based on the
repetitive core domain of one of the Araneus diadematus
dragline silk proteins,[6] has been investigated thoroughly.[7]
Spider silk hydrogels exhibit shear-thinning behaviour,[7a]
which is a crucial requirement for 3D printing and biofabri-
cation[8] or the administration as drug depots.[9] Modifications
during processing allowed incorporating water-soluble bio-
logicals in eADF4(C16) hydrogels and their sustained
release.[9] However, several pharmaceutical active agents
show only poor water solubility or stability and cannot be
delivered using hydrogels. Therefore, the aim of this study was
to provide drug depots based on gels with the possibility to
formulate both water-soluble and water-insoluble drugs.
Ions such as potassium or phosphate effect folding[10] of
spider silk proteins,[11] and this kosmotropic ion-triggered
structure formation is part of the natural assembly process of
spider silk.[12] However, protein folding effects can be also
achieved using non-physiological organic co-solvents when
they are fully miscible in water.[13] The presence of organic co-
solvents with varying polarity can change the solvation
conditions, often leading to protein conformational
changes.[13] The assumption that especially hydrophobic
interactions and hydrogen bonds are driving forces of protein
folding is commonly agreed with.[14] Besides intramolecular
folding, also intermolecular structure formation can be
obtained in aqueous–organic solvents yielding protein assem-
bly and fibrillisation.[15]
Therefore, we investigated a novel gelation route of
recombinant spider silk proteins upon fibril assembly in
aqueous–organic micro-heterogeneous phases, including the
underlying assembly mechanism, and we provide evidence for
the use of gels made therewith as drug depots as well as their
3D printability.
Recombinant spider silk proteins have previously been
reported to assemble into fibrils and/or particles upon
addition of potassium phosphate, and the gained morphology
depends on the concentration of the kosmotropic salt.[6, 11,16]
Here, we investigated assembly in the presence of co-solvents
and -solutes such as DMSO and potassium phosphate and
obtained characteristic fibrillisation-based sigmoidal turbidity
curves[7a] (Figure 1A). In order to gain more mechanistic
insights into this behaviour, three spider silk protein variants
differing in their net charge but with otherwise identical
amino acid compositions were analysed (see Experimental
Section). Potassium phosphate induced fibrillisation of the
negatively charged eADF4(C16),[6] which was used as positive
control, and its mechanism of fibrillisation has been reported
previously.[11] The positively charged eADF4(k16)[17] showed
accelerated protein aggregation and phase separation in the
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presence of potassium phosphate, and the uncharged eADF4-
(W16)[18] showed particle formation, indicating a shift towards
lower critical potassium phosphate concentrations for particle
formation for this variant. The impact of DMSO was analysed
in aqueous–organic binary mixtures[19] with different volumes.
Like in potassium phosphate, in DMSO the uncharged
variant showed the fastest nucleation and fibril growth
based on its low electrostatic repulsion, which was least
controllable. The positively charged variant showed a fast
turbidity increase assuming an aggregation-driven process,
yielding gelly morphologies, but no stable gels. The negative
variant exhibited the longest lag-phase and yielded well-
controllable gels. As this protein is based on the naturally
occurring spider silk consensus sequence, the best-controlled
assembly behaviour was expected. It has to be mentioned that
the addition of DMSO yielded decreased turbidity for all
variants and additionally slowed down fibrillisation for
eADF4(W16) and extended the lag-phase for eADF4(k16).
Interestingly, gel stability was dependent on both the net
charge of the eADF4 variant, as already mentioned above,
and the organic additive (Figure 1B), indicating charge-
dependent intra- and intermolecular structure formation, as
the variants differed in only one amino acid per module in the
repetitive sequence. Hydrogen bonds between DMSO and
glutamic acid residues within eADF4(C16) were likely the
reason for higher gel stability but were independent of the
DMSO concentration. In contrast, DMSO seemed to stabilise
eADF4(W16) gels with increasing concentration, based on
hydrogen bonds with glutamine residues. The stability of
eADF4(k16) gelly morphologies decreased with increasing
concentration of DMSO, which forms fewer hydrogen bonds
with lysine residues.
To investigate the influence of solvent polarity, 3% (w/v)
eADF4(C16) solutions, as the best controllable ones, were
used in water, and in blends with less polar DMF and with
least polar DMSO. Additionally, to gradually increase the
concentration of DMSO, 3 % (w/v) eADF4(C16) solutions
were dialysed against this solvent. The organo-dialysis step
allowed a fast solvent exchange and simultaneously lead to
highly transparent gels. The effect on protein structure
formation was analysed using ATR-FTIR spectroscopy.
Secondary structures in gels were derived from the peaks of
the amide I and II bands at 1720–1490 cm1 (Figure 2A) and
were quantified using Fourier self-deconvolution.
The highest b-sheet content (39 1%) was found in case
of Tris-hydrogels as well as gels made in DMSO blends. Tris/
DMSO-gels from organo-dialysis showed a lower b-sheet
content of 28 5%, which might be caused by faster gelation.Figure 1. Assembly of three eADF4 variants in presence of different
Tris/DMSO volume ratios in comparison to that in presence of
150 mm potassium phosphate (KPi). I–III in 10 mm Tris pH 7.5, IV–VI
in presence of 150 mm KPi, VII–IX in presence of 5% (v/v) DMSO, X–
XII in presence of 15% (v/v) DMSO, and XIII–XV in presence of 30%
(v/v) DMSO. A) Turbidity measurements of eADF4(C16), eADF4(k16),
and eADF4(W16) as indicated during fibril formation. Fibril assembly
is normalised to KPi samples. The arrow indicates particle formation
in case of eADF4(W16). B) Stereomicroscopic images of gels at
conditions as indicated; scale bars 1 mm. Image VI shows reflections
of the light source appearing as a ring. Qualitative gel stabilities are
indicated by stability bars.
Figure 2. Impact of organic additives on spider silk gels: Comparison
of gels from initial 3% (w/v) eADF4(C16) silk solutions in 10 mm Tris
pH 7.5 (Tris100) diluted with one third volume ratio of the co-solvents
water (Tris67), DMF (Tris67/DMF33), or DMSO (Tris67/DMSO33), and
gels made upon dialysis against DMSO (DMSO100x/Trisx). A) Mean
ATR-FTIR spectra of the co-solvent gels. B) TEM images of silk fibrils
in the co-solvent gels. C) SEM images of the respective co-solvent gels
after freeze-drying. D) Mean amplitude sweep rheological measure-
ments of co-solvent gels. E) Normalised cumulative release of 6-
mercaptopurine from 2% (w/v) eADF4(C16) Tris100 gel (green data
points) and from 2% (w/v) eADF4(C16) Tris67/DMSO33 gel (blue data
points) at 37 8C. F) Photo of a 3D printed tarantula from DMSO blend
gels (Tris67/DMSO33). Scale bar as indicated.
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Far fewer b-sheets were found in the presence of water (24
5%) or in case of blends with DMF (22 4%). The formation
of fibrillar networks was pronounced in the presence of
DMSO, indicated by intertwined fibrils as found in TEM
images (Figure 2B). In presence of DMF or water, signifi-
cantly shorter fibrils were formed. SEM imaging showed
a sheet-like structure for lyophilised co-solvent gels with
DMF. Fused pore structures were found upon water addition.
Strikingly, a highly fibrillary and porous structure was present
in case of DMSO-triggered gelation. At higher magnification,
pore walls showed fibrillar sub-structures in Tris/DMSO-gels
after organo-dialysis (Figure 2C). Sharp pore structures were
found in Tris-gels with smooth, sheet-like pores as reported
previously.[7a] Fibrils in Tris-hydrogels might have collapsed
into these sheet structures upon freeze-drying. Rheological
characterisation (Figure 2D) showed slightly higher storage
and loss moduli for 2% (w/v) eADF4(C16) Tris/DMSO-gels
in comparison to 3% (w/v) eADF4(C16) Tris-hydrogels.
Nonetheless, for Tris/DMSO-gels and Tris-hydrogels, moduli
were in the same range, and similar yield points were
detected, indicating comparable visco-elastic properties. 3%
(w/v) eADF4(C16) Tris/DMSO-gels from organo-dialysis
showed the highest storage modulus and a slight shift in the
yield point towards higher oscillation strain, indicating higher
resistance of the material until break.
Nonetheless, the new gels showed typical spider silk
hydrogel shear-thinning behaviour and stability (Fig-
ure S1A,B). Accordingly, using a RegenHU bioplotter, multi-
layer scaffolds with high shape stability could be 3D printed
using the DMSO blend gels (Figure 2F, Figure S3, and
Video S4).
To test the application of such gels as drug depots,
fluorescein (FITC) was loaded as a first model substance into
Tris/DMSO-gels, and a comparison was made to Tris-hydro-
gels regarding loading and release at 37 8C. Both gel types
showed the same release profile (Figure S2), indicating the
possibility of generating injectable or transdermal drug-
loaded gel depots. Further, the poorly water-soluble 6-
mercaptopurine, as clinically relevant cytostatic drug, was
loaded into the DMSO-phase of 2% (w/v) eADF4(C16)
blend gels. The drug was incorporated by non-covalent
interactions, but in case a reversible coupling is intended,
a recently published system with a different spider silk variant
can be used.[20] Upon non-covalent introduction in Tris-
hydrogels, the water-insoluble drug aggregated during the
gelation process and accumulated at the bottom of the gel. In
the DMSO blend gel, however, loading and release could be
accomplished. These results confirmed the suitability of co-
solvent-produced spider silk gels with clinically relevant
substances as injectable and even 3D printable drug depots.
Finally, we wanted to unravel the driving force of spider
silk assembly in presence of co-solvents. The herein reported
route towards spider silk gel formation in aqueous–organic
binary mixtures is driven in part by structure formation at
organic–water interfaces (Scheme 1). eADF4(C16) was found
to form water-insoluble b-sheet structures in microcapsules[21]
with barrier function[22] upon adsorption at aqueous–organic
interfaces. In case of aqueous–organic binary mixtures, micro-
emulsions can form in presence of organic co-solvents such as
DMSO[23] or DMF,[13] which are miscible in water.
The formed interphases are micro-heterogeneous[24] and
are based on the interaction of hydrogen bond[25] forming
molecules. These interphases can be described by a side-by-
side arrangement of both solvents in molecular clusters.[25]
DMSO and DMF are amphiphilic molecules, which can form
hydrogen bonds, for example, with water but also enable
hydrophobic interactions among them or with other mole-
cules such as proteins. Similarly, eADF4 exhibits amphiphilic
properties due to its amino acid sequence[26] and can therefore
Scheme 1. Illustration of routes towards drug depots made of recombi-
nant spider silk proteins. A) Potassium phosphate-induced co-precip-
itation of microparticles and any type of drugs. B) Hydrogels cannot
incorporate hydrophobic but only hydrophilic drugs during gelation.
C) New route of gel formation, allowing the incorporation of hydro-
philic as well as hydrophobic drugs. D) Microcapsules can incorporate
hydrophilic, hydrophobic, and amphiphilic (at the aqueous–organic
interface) drugs. Aqueous–organic binary mixtures as seen in (C)
represent intermediate conditions between hydrogel formation in one
homogenous (aqueous) phase (B) and phase-separation-induced b-
sheet formation at the water–oil interface (D). X = selected amino
acids of the silk variants, that is, glutamic acid, glutamine, or lysine.
Angewandte
ChemieCommunications
11849Angew. Chem. Int. Ed. 2021, 60, 11847 –11851  2021 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH www.angewandte.org
interact with hydrophobic as well as hydrophilic drugs/
molecules. Charged amino acid residues can form hydrogen
bonds with DMSO to a varying degree, and negatively
charged molecules are favoured over uncharged or positively
charged ones.[27]
Spider silk gels made out of aqueous–organic co-solvents
enlarge the range of applications of spider silk-based materi-
als since material properties can be controlled by the choice of
the co-solvent and of the used spider silk variant. DMSO is
FDA approved[28] in topical formulations at concentrations at
approximately 30% (v/v). Based on our results it can be
applied in spider silk gels in pharmaceutical formulations, e.g.
for transdermal applications. These gels allow formulation of
water-insoluble drugs along with adjustable organic content
to yield biocompatible, biodegradable, non-toxic, non-inflam-
matory, transdermal, injectable, and even 3D printable drug
depots. Depending on the application, the drug–silk inter-
action can be further controlled, for example, by reversible
covalent bonds.[20]
Experimental Section
The engineered spider silk protein eADF4(C16) comprises 16 repeats
of the consensus sequence GSSAAAAAAAASGPGGYG-
PENQGPSGPGGYGPGGP (named C-module). The C-module is
based on the consensus sequence of the repetitive core domain of the
MaSp2 dragline silk fibroin 4 of the European garden spider Araneus
diadematus.[6] eADF4(C16) was purchased from AMSilk GmbH
(Planegg, Germany). In variant eADF4(k16),[17] all glutamic acid
residues are substituted with lysine and in eADF4(W16)[18a] with
glutamine ones. Both proteins were produced and purified as
reported earlier.[6,17, 18] Spider silk proteins were dissolved in 6 m
guanidinium thiocyanate (Carl Roth, Karlsruhe, Germany) and
dialysed against 10 mm Tris buffer, pH 7.5 for several hours, whereas
the dialysis of eADF4(W16) was done at 4 8C. Concentration adjust-
ment was conducted, if necessary, by follow-up dialysis in 20% (w/v)
poly(ethylene glycol) (PEG, 20 kDa, Carl Roth, Karlsruhe, Germany)
as reported previously[7a] or using a high vacuum concentrator
(Speedvac, Eppendorf). For biphasic gels, co-solvents or co-solute
buffers were blended with 3% (w/v) silk solutions and gelled at 37 8C.
For organo-dialysis gels, 3% (w/v) silk solutions were dialysed against
small volumes (1:100 volume ratio) of DMSO (Carl Roth, Karlsruhe,
Germany) at RT for 4 h without further thermal treatment.
For analysis of the gelation kinetics of recombinant spider silk
proteins, turbidity changes were monitored at 570 nm using a micro-
plate reader (Mithras LB 940, Berthold Technologies, Germany).
Triplicates of 100 mL aliquots were prepared for all solutions (3%
(w/v) eADF4(C16), 2% (w/v) eADF4(k16), and 1% (w/v) eADF4-
(W16)). Spider silk solutions were diluted by addition of different
volumes of DMSO to reach final concentrations of 5, 15, and 30%
(v/v) DMSO in the blend. As a control, 150 mm potassium phosphate
was used as fibrillisation trigger, and data were normalised to this
samples endpoint.
Gel samples were transferred on glass slides for image collection
using a Leica M205C stereomicroscope (Wetzlar, Germany) with
Leica LAS software and light reflection from dark field mode. The
microscope was equipped with a polarisation lens and a 0.63 
objective. For scanning electron microscopy (SEM), lyophilised gel
samples were investigated after platinum sputtering (2 nm). Images
were recorded using a Thermo Scientific (FEI) Apreo VS with a Field
Emission Gun at 2 kV and a SE2-detector. Transmission electron
microscopy (TEM) images of stained (2% uranyl acetate) spider silk
fibrils immobilised on Pioloform-coated 100-mesh copper grids
(Plano GmbH, Germany) were recorded using a JEM-2100 TEM
(JEOL, Japan), operated at 80 kV, and imaging was carried out using
a 4000  4000 charge-coupled device camera (UltraScan 4000, Gatan,
USA) and Gatan Digital Micrograph software (version 1.83.842).
Rheological behaviour was investigated using a Discovery Hybrid
Rheometer 3 (TA, USA) with a plate–plate geometry (diameter
25 mm) at 25 8C. To prevent drying effects on the gels, a wet sponge
adapter was used. Amplitude sweeps (n = 3) were recorded as
triplicates at 31.4 rads1 and a strain of 0.1–1000 %.
Attenuated total reflectance-Fourier transformation infrared spec-
troscopy (ATR-FTIR) was conducted with lyophilised gel samples.
Spectra (n = 3) were recorded using a Bruker Tensor 27 (Ettlingen,
Germany) with a germanium crystal at a spectral resolution of 2 cm1
with 100 scans. Atmospheric compensation algorithm was applied in
OPUS 8.0 software to correct water vapour and carbon dioxide
fluctuations during the measurement. Fourier self-deconvolution was
carried out as reported previously[29] with band assignment for partial
secondary structure determination.[30]
To study the release of 6-mercaptopurine (Sigma, USA) from 2%
(w/v) Tris100 and 2% (w/v) Tris67/DMSO33 eADF4(C16) gels, the drug
was dissolved in 20 mL DMSO and added to the spider silk solutions
or the DMSO-phase. Triplicate release measurements were con-
ducted in 1:1 blends of MilliQ water:DMSO. UV absorbance was
monitored using a UV spectrometer (Genesys 10S UV/Vis, Thermo
Scientific). Spectra were recorded between 200 and 600 nm, and peak
maxima at 328 nm were used to determine cumulative release curves.
3D dispense plotting was carried out using a RegenHU 3D Discovery
Gen1 (Switzerland) bioplotter with cartridges size 3cc and according
pistons. The printing speed was pre-set to 10 mms1. 2% (w/v) Tris67/
DMSO33 eADF4(C16) gels were printed with Luer lock plastic
needles with an inner diameter of 0.41 mm and an applied pressure of
0.3 bar.
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